Skip to main content

Table 1 Demographic and clinical characteristics of PsAID < 4 patients

From: Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study

 

PsAID < 4, N (122)

PsAID ≥ 4, N (101)

P value

Male, n (%)

70 (57.4)

51 (50.5)

NS

Age, mean (SD), year

54.5 (12.7)

51.7 (12.7)

NS

BMI, mean (SD) (kg/m2)

27.1 (3.9)

26.3 (4.8)

NS

CRP (mg/L), mean (SD)

2.8 (3.3)

4.6 (8.4)

< 0.05

Comorbidities, n (%)

70 (57.4)

43 (42.6)

NS

 Dyslipemia

40 (32.8)

29 (28.7)

NS

 HBP

33 (27.0)

27 (26.7)

NS

 Obesity

30 (24.6)

16 (15.8)

NS

 DM

12 (9.8)

9 (8.9)

NS

PsA clinical pattern, n (%)

 Axial

3 (2.5)

4 (4.0)

 

 Peripheral

107 (87.7)

79 (78.2)

 

 Mixed

12 (9.8)

18 (17.8)

 

Dactylitis

64 (52.5)

47 (46.5)

NS

Enthesitis

45 (36.9)

35 (34.7)

NS

DIP

45 (36.9)

48 (47.5)

NS

Familial history, n (%)

 Psoriasis

60 (49.2)

51 (50.5)

NS

 PsA

11 (9.0)

16 (15.8)

NS

Ankylosing spondylitis

2 (1.6)

0 (0.0)

NS

PsA duration, mean (SD), years

9.6 (7.9)

9.7 (7.7)

NS

Skin symptoms duration, mean (SD), years

21.6 (14.5)

22.9 (15.0)

NS

Articular symptoms duration, mean (SD), years

11.9 (8.7)

12.6 (10.0)

NS

Radiologic findings

 Erosions in hands, n (%)

40 (32.8)

43 (42.6)

NS

 Erosions in feet, n (%)

33 (27.0)

32 (31.7)

NS

  1. BMI body mass Index, CRP C-reactive protein, HBP high blood pressure, DIP distal interphalangeal joint disease, DM diabetes mellitus, SD standard deviation, NS non-significant